Inventor · disambiguated record
Ben K. Seon
Also filed as: SEON BEN K
9 granted patents·7 pending applications·359 citations·filing 1992–2022
90Inventor score
Top patents by PatentIndex Score
16 records- 0192US6190660B1Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapyHEALTH RESEARCH INC·Filed 2000·Granted Feb 20, 2001·47 cites·25 claims
- 0292US5644033AMonoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatmentHEALTH RESEARCH INC·Filed 1992·Granted Jul 1, 1997·133 cites·12 claims
- 0391US5928641AAnti-endoglin monoclonal antibodies and their use in antiangiogenic therapyHEALTH RESEARCH INC·Filed 1997·Granted Jul 27, 1999·91 cites·42 claims
- 0488US7097836B1Method for increasing the efficacy of anti-tumor agents by anti-endoglin antibodyHEALTH RESEARCH INC·Filed 2003·Granted Aug 29, 2006·29 cites·9 claims
- 0579US7691374B2Method for increasing the efficacy of anti-tumor agents by anti-endoglin antibodyHEALTH RESEARCH INC·Filed 2006·Granted Apr 6, 2010·1 cites·6 claims
- 0675US6200566B1Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapyHEALTH RESEARCH INC·Filed 1999·Granted Mar 13, 2001·39 cites·16 claims
- 0758US2020087389A1Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agentsTRACON PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0855US2018371072A1Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agentsTRACON PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0952US5441871AMonoclonal antibody reactive to human leukemia and lymphoma cells and methods of using same for diagnosis and treatmentHEALTH RESEARCH INC·Filed 1992·Granted Aug 15, 1995·11 cites·4 claims
- 1051US2024101701A1Antibody-derived t cell activating technologiesHEALTH RESEARCH INC·Filed 2022·Application pending·0 cites
- 1149US5407805AMonoclonal antibody reactive to various human leukemia and lymphoma cells and methods of using same for diagnosis and treatmentHEALTH RESEARCH INC·Filed 1992·Granted Apr 18, 1995·8 cites·2 claims
- 1248US2012244147A1Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agentsTHEUER CHARLES P·Filed 2010·Application pending·0 cites
- 1348US2016222083A1Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglinHEALTH RESEARCH INC·Filed 2016·Application pending·0 cites
- 1443US2018057602A1Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agentsTRACON PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1542US2020165350A1Strong potentiation of immune checkpoint blockade therapy of cancer by combination with endoglin-targeting therapyHEALTH RESEARCH INC·Filed 2018·Application pending·0 cites
- 1640US9315582B2Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglinSEON BEN K·Filed 2012·Granted Apr 19, 2016·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Ben K. Seon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →